DALLAS BOWLES: Open Payments
NPI 1588154124 · CEDAR CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,265 in 43 payments from 11 companies in 2025. Trend: 2023 $691 · 2024 $0 · 2025 $1,265
Food & beverage: $1,265
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $285 |
| Otsuka America Pharmaceutical, Inc. | 3 | $233 |
| Axsome Therapeutics, Inc. | 4 | $191 |
| Janssen Pharmaceuticals, Inc | 4 | $178 |
| Neurocrine BioSciences, Inc. | 4 | $90 |
| E.R. Squibb & Sons, L.L.C. | 5 | $80 |
| Alkermes, Inc. | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $60 |
| Lundbeck LLC | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
Products named: VRAYLAR, ABILIFY MAINTENA, Auvelity, INVEGA SUSTENNA, INGREZZA, COBENFY, TRINTELLIX, REXULTI.
Industry payments across UT — which companies pay providers there.
